4//SEC Filing
Quan Venture Fund II, L.P. 4
Accession 0001209191-21-024242
CIK 0001807120other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:25 PM ET
Size
11.2 KB
Accession
0001209191-21-024242
Insider Transaction Report
Form 4
Quan Venture Fund II, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2021-03-30+280,991→ 4,720,830 total - Conversion
Common Stock
2021-03-30+4,439,839→ 4,439,839 total - Conversion
Series B Preferred Stock
2021-03-30−458,016→ 0 total→ Common Stock (280,991 underlying) - Conversion
Series A Preferred Stock
2021-03-30−7,236,938→ 0 total→ Common Stock (4,439,839 underlying)
Footnotes (1)
- [F1]All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001750370
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:25 PM ET
- Size
- 11.2 KB